EUVIMEDEUVIMED entdecken
Crossref

The post-neoadjuvant absolute lymphocyte count reflects the pathological response and local tumor control in pancreatic cancer

Ryo Saito, Hidetake Amemiya, Wataru Izumo, Taishu Oka, Suguru Maruyama, Koichi Takiguchi, Katsutoshi Shoda, Kensuke Shiraishi, Shinji Furuya, Yoshihiko Kawaguchi, Hiromichi Kawaida, Daisuke Ichikawa

Surgery Today · 2026-11 · 56 (11) · 2684-2691

DOI: 10.1007/s00595-026-03412-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, online erschienen am 13.07.2026. Verfasst von Ryo Saito und 11 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Surgery, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 4093898, Japan. rsaitoh@yamanashi.ac.jp. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neoadjuvant Therapy, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Predictive markers of the response to neoadjuvant chemotherapy (NAC) in pancreatic cancer are limited. We investigated whether the absolute lymphocyte count (ALC), a surrogate marker of host immune competence, could predict the pathological response to NAC. METHODS: This retrospective single-center study included patients with pancreatic ductal adenocarcinoma who underwent pancreatectomy after NAC (2019 and 2025). The pathological response was classified as good (JPS grade ≥ 2) or poor (grade 1a/1b). Logistic regression was used to identify predictors of a good response. Locoregional recurrence was analyzed using competing risk methods. RESULTS: Among the 110 patients, 20 (18.2%) achieved a good pathological response. The Preoperative ALC (measured immediately before surgery) was higher in the good-response group (median 1544 vs. 1053/µL, p = 0.014). In a multivariable analysis, ALC independently predicted a good response (OR per 500/µL, 1.59; 95% CI 1.09-2.32; p = 0.016), whereas CA19-9 was not significant. Patients with a good pathological response had a lower cumulative incidence of locoregional recurrence (3-year: 7.0% vs. 37.6%, p = 0.036). CONCLUSIONS: Preoperative ALC predicts the pathological response to NAC and reflects host immune competence relevant to local tumor control. As a simple and widely available biomarker, ALC may aid in the perioperative decision-making for pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeoadjuvant TherapyCarcinoma, Pancreatic DuctalHumansLymphocyte CountRetrospective StudiesPancreatectomyFemaleMaleNeoplasm Recurrence, LocalTreatment OutcomeAgedMiddle AgedPredictive Value of Tests

Stichwörter der Autor:innen

Absolute lymphocyte countHost immunityNeoadjuvant chemotherapyPancreatic cancerPathological response

Autor:innen und Institutionen

  • First Department of Surgery, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 4093898, Japan. rsaitoh@yamanashi.ac.jp.
  • First Department of Surgery, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 4093898, Japan.

Zitieren

APA

Saito, R., Amemiya, H., Izumo, W., Oka, T., Maruyama, S., Takiguchi, K., Shoda, K., Shiraishi, K., Furuya, S., Kawaguchi, Y., Kawaida, H., & Ichikawa, D. (2026). The post-neoadjuvant absolute lymphocyte count reflects the pathological response and local tumor control in pancreatic cancer. Surgery Today, 56(11), 2684-2691. https://doi.org/10.1007/s00595-026-03412-y

Vancouver

Saito R, Amemiya H, Izumo W, Oka T, Maruyama S, Takiguchi K, et al. The post-neoadjuvant absolute lymphocyte count reflects the pathological response and local tumor control in pancreatic cancer. Surgery Today. 2026;56(11):2684-2691. doi:10.1007/s00595-026-03412-y

BibTeX
@article{Saito2026,
  author = {Saito, Ryo and Amemiya, Hidetake and Izumo, Wataru and Oka, Taishu and Maruyama, Suguru and Takiguchi, Koichi and Shoda, Katsutoshi and Shiraishi, Kensuke and Furuya, Shinji and Kawaguchi, Yoshihiko and Kawaida, Hiromichi and Ichikawa, Daisuke},
  title = {The post-neoadjuvant absolute lymphocyte count reflects the pathological response and local tumor control in pancreatic cancer},
  journal = {Surgery Today},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {2684--2691},
  doi = {10.1007/s00595-026-03412-y}
}
Kostenlos starten →